GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (XPAR:ALMKT) » Definitions » COGS-to-Revenue

Mauna Kea Technologies (XPAR:ALMKT) COGS-to-Revenue : 0.36 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Mauna Kea Technologies COGS-to-Revenue?

Mauna Kea Technologies's Cost of Goods Sold for the six months ended in Dec. 2023 was €1.31 Mil. Its Revenue for the six months ended in Dec. 2023 was €3.67 Mil.

Mauna Kea Technologies's COGS to Revenue for the six months ended in Dec. 2023 was 0.36.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Mauna Kea Technologies's Gross Margin % for the six months ended in Dec. 2023 was 64.37%.


Mauna Kea Technologies COGS-to-Revenue Historical Data

The historical data trend for Mauna Kea Technologies's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies COGS-to-Revenue Chart

Mauna Kea Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.33 0.26 0.27 0.20

Mauna Kea Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.27 0.27 0.12 0.36

Mauna Kea Technologies COGS-to-Revenue Calculation

Mauna Kea Technologies's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2.119 / 10.48
=0.20

Mauna Kea Technologies's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1.306 / 3.665
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mauna Kea Technologies  (XPAR:ALMKT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Mauna Kea Technologies's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1.306 / 3.665
=64.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Mauna Kea Technologies COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies (XPAR:ALMKT) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (XPAR:ALMKT) Headlines

No Headlines